AstraZeneca PLC (AZN) Presents at ESMO Investor Science Broker Conference - (Transcript)Seeking Alpha • 09/21/21
Breakthrough AstraZeneca Breast Cancer Drug Massively Reduces Disease and Fatalities in TrialThe Motley Fool • 09/21/21
AstraZeneca's Enhertu Posts Substantial Clinical Benefit Over Roche's Kadcyla In Breast Cancer TrialsBenzinga • 09/20/21
AstraZeneca Touts Longest Survival Update In Lung Cancer Setting With Imfinzi/Chemo DataBenzinga • 09/20/21
AstraZeneca PLC: £2bn added to the value after "ground-breaking" breast cancer trial results. But just how much higher will its shares go?Proactive Investors • 09/20/21
LogicBio Therapeutics to Present at the H.C. Wainwright 23rd Annual Global Investment ConferencePRNewsWire • 09/10/21
Covid booster jab not needed for everyone, says AstraZeneca vaccine creatorProactive Investors • 09/10/21
AstraZeneca's Imfinzi / Tremelimumab Combo Regime Shows Survival Benefit In Lung Cancer SettingsBenzinga • 09/09/21
AstraZeneca COVID-19 vaccine may trigger 'very rare' nerve disease, European regulator saysMarket Watch • 09/09/21
AstraZeneca asthma candidate passes clinical trials with flying coloursProactive Investors • 09/09/21
European Medicines Agency Lists Nerve Disorder As “Very Rare” Side Effect Of AstraZeneca Covid-19 VaccineForbes • 09/09/21